–
Prof. Tamar Peretz will fill the CEO role for the time being.
–
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Avigdor Kaplan is stepping down as CEO of Hadassah Medical Center. The hospital’s board of directors has accepted Kaplan’s resignation. Prof. Tamar Peretz, head of Haddasah’s Sharett Institute of Oncology, will fill the CEO role for the time being.
Two weeks ago, the Jerusalem District Court approved the creditors’ arrangement at Hadassah. At the end of a severe crisis that almost led to the hospital’s closure, the Finance and Health ministries reached agreement with the Hadassah organization, and representatives of the doctors, the nurses, and the administrative and domestic staff, on a recovery plan.
–
–
The agreement states that the CEO and the chairman of the hospital will be restricted to two terms of four years, with the state’s approval being required for a second term. Furthermore, the directors of the Ministry of Finance and the Ministry of Health will be entitled to initiate a discussion by the board of directors in the event of deviation from the recovery plan, or because of a need to dismiss the CEO before his or her term ends.
–
–
Published by Globes [online], Israel business news – www.globes-online.com
